Open Close

New England Biolabs picks LogMeIn's IoT platform

LogMeIn, Inc. (NASDAQ: LOGM) said that New England Biolabs has selected LogMeIn´s Xively Cloud Services platform for its Internet of Things implementation, which will help to optimize and scale the company´s real-time supply chain offering for enzymes and related products used in DNA-based research.

New England Biolabs´ new IoT-connected enzyme freezers are designed to give scientists much faster access to the products necessary for accelerating genomic research.

New England Biolabs produces the world´s largest selection of recombinant and native enzymes for genomic and molecular biology research.

LogMeIn transforms the way people work and live through secure connections to the computers, devices, data, and people that make up their digital world. The company is headquartered in Boston´s Innovation District with offices in Australia, Hungary, India, Ireland, and the UK.


If you enjoyed this post, please consider leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.